MENU
+Compare
OCS
Stock ticker: NASDAQ
AS OF
Dec 3, 04:59 PM (EDT)
Price
$19.02
Change
+$0.23 (+1.22%)
Capitalization
1.1B

OCS Oculis Holding AG Forecast, Technical & Fundamental Analysis

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care... Show more

OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for OCS with price predictions
Nov 28, 2025

OCS in +0.36% Uptrend, rising for three consecutive days on November 25, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OCS advanced for three days, in of 157 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for OCS moved above the 200-day moving average on November 07, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

OCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for OCS moved out of overbought territory on October 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OCS as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

OCS moved below its 50-day moving average on November 19, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OCS crossed bearishly below the 50-day moving average on November 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OCS entered a downward trend on November 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.757) is normal, around the industry mean (27.312). P/E Ratio (63.076) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (321.020).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Bahnhofstrasse 7
Phone
+41 417119325
Employees
N/A
Web
https://www.oculis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSCYX34.54N/A
N/A
BNY Mellon Opportunistic Small Cap Y
AXVNX19.45N/A
N/A
Acclivity Small Cap Value N
NBPBX52.90N/A
N/A
Neuberger Berman Large Cap Value Adv
LMSAX41.72N/A
N/A
ClearBridge Small Cap A
FMIUX37.58N/A
N/A
FMI Common Stock Institutional

OCS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OCS has been loosely correlated with CGEN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OCS jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-1.16%
CGEN - OCS
34%
Loosely correlated
-0.33%
SNSE - OCS
32%
Poorly correlated
-1.17%
GRI - OCS
30%
Poorly correlated
-1.02%
PRAX - OCS
29%
Poorly correlated
-2.73%
CGON - OCS
29%
Poorly correlated
-4.35%
More